Citation: Ph. Sugarbaker, INTRAPERITONEAL CHEMOTHERAPY AND CYTOREDUCTIVE SURGERY FOR THE PREVENTION AND TREATMENT OF PERITONEAL CARCINOMATOSIS AND SARCOMATOSIS, Seminars in surgical oncology, 14(3), 1998, pp. 254-261
Authors:
JACQUET P
AVERBACH A
STUART OA
CHANG D
SUGARBAKER PH
Citation: P. Jacquet et al., HYPERTHERMIC INTRAPERITONEAL DOXORUBICIN - PHARMACOKINETICS, METABOLISM, AND TISSUE DISTRIBUTION IN A RAT MODEL, Cancer chemotherapy and pharmacology, 41(2), 1998, pp. 147-154
Authors:
JACQUET P
AVERBACH A
STEPHENS AD
STUART OA
CHANG D
SUGARBAKER PH
Citation: P. Jacquet et al., HEATED INTRAOPERATIVE INTRAPERITONEAL MITOMYCIN-C AND EARLY POSTOPERATIVE INTRAPERITONEAL 5-FLUOROURACIL - PHARMACOKINETIC STUDIES, Oncology, 55(2), 1998, pp. 130-138
Authors:
GEIGER D
MPINGA E
STEVES MA
SUGARBAKER PH
Citation: D. Geiger et al., FEMORAL NEUROPATHY - UNUSUAL PRESENTATION FOR RECURRENT LARGE-BOWEL CANCER, Diseases of the colon & rectum, 41(7), 1998, pp. 910-913
Authors:
PORTILLA AG
DELECEA CM
STEVENS M
SUGARBAKER PH
Citation: Ag. Portilla et al., RELEVANT POINTS TO CONSIDER FOR SELECTION OF PATIENTS WITH PERITONEALCARCINOMATOSIS FOR CYTOREDUCTIVE SURGERY AND IP CHEMOTHERAPY, British Journal of Surgery, 85, 1998, pp. 21-22
Authors:
YU W
WHANG I
SUH I
AVERBACH A
CHANG D
SUGARBAKER PH
Citation: W. Yu et al., PROSPECTIVE RANDOMIZED TRIAL OF EARLY POSTOPERATIVE INTRAPERITONEAL CHEMOTHERAPY AS AN ADJUVANT TO RESECTABLE GASTRIC-CANCER, Annals of surgery, 228(3), 1998, pp. 347-353
Citation: W. Lawrence et al., PROSPECTIVE RANDOMIZED TRIAL OF EARLY POSTOPERATIVE INTRAPERITONEAL CHEMOTHERAPY AS AN ADJUVANT TO RESECTABLE GASTRIC-CANCER - DISCUSSION, Annals of surgery, 228(3), 1998, pp. 353-354
Citation: B. Berthet et Ph. Sugarbaker, RATIONALE FOR PERIOPERATIVE INTRAPERITONEAL CHEMOTHERAPY AFTER CURATIVE RESECTION OF PRIMARY ABDOMINOPELVIC SARCOMA, Annales de chirurgie, 52(7), 1998, pp. 607-611
Authors:
YU WS
WHANG IW
AVERBACH A
CHANG D
SUGARBAKER PH
Citation: Ws. Yu et al., MORBIDITY AND MORTALITY OF EARLY POSTOPERATIVE INTRAPERITONEAL CHEMOTHERAPY AS ADJUVANT THERAPY FOR GASTRIC-CANCER, The American surgeon, 64(11), 1998, pp. 1104-1108
Citation: Ag. Portilla et al., CLINICAL PATHWAY FOR PERITONEAL CARCINOMATOSIS FROM COLON AND RECTAL-CANCER - GUIDELINES FOR CURRENT PRACTICE, Tumori, 83(4), 1997, pp. 725-728
Authors:
RONNETT BM
SHMOOKLER B
DIENERWEST M
SUGARBAKER PH
KURMAN RJ
Citation: Bm. Ronnett et al., IMMUNOHISTOCHEMICAL EVIDENCE SUPPORTING THE APPENDICEAL ORIGIN OF PSEUDOMYXOMA PERITONEI IN WOMEN, International journal of gynecological pathology, 16(1), 1997, pp. 1-9
Citation: Bm. Ronnett et al., THE MORPHOLOGIC SPECTRUM OF OVARIAN METASTASES OF APPENDICEAL ADENOCARCINOMAS - A CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL ANALYSIS OF TUMORS OFTEN MISINTERPRETED AS PRIMARY OVARIAN-TUMORS OR METASTATIC TUMORS FROM OTHER GASTROINTESTINAL SITES, The American journal of surgical pathology, 21(10), 1997, pp. 1144-1155
Citation: D. Zanarini et Ph. Sugarbaker, EXTREMITY SOFT-TISSUE SARCOMA WITH METASTASES TO ABDOMINOPELVIC SURFACES, Journal of surgical oncology, 64(1), 1997, pp. 68-72
Authors:
JACQUET P
JELINEK JS
CHANG D
KOSLOWE P
SUGARBAKER PH
Citation: P. Jacquet et al., ABDOMINAL COMPUTED TOMOGRAPHIC SCAN IN THE SELECTION OF PATIENTS WITHMUCINOUS PERITONEAL CARCINOMATOSIS FOR CYTOREDUCTIVE SURGERY (VOL 181, PG 530, 1995), Journal of the American College of Surgeons, 182(1), 1996, pp. 80-80
Citation: Am. Averbach et al., CURATIVE TREATMENT OF GASTROINTESTINAL CANCER .1. THE SURGEON AS A PROGNOSTIC VARIABLE, GI cancer, 1(4), 1996, pp. 227-238
Citation: Am. Averbach et al., CURATIVE TREATMENT OF GASTROINTESTINAL CANCER .2. SURGICALLY DIRECTEDADJUVANT REGIONAL CHEMOTHERAPY, GI cancer, 1(4), 1996, pp. 239-246
Citation: Fan. Zoetmulder et Ph. Sugarbaker, PATTERNS OF FAILURE FOLLOWING TREATMENT OF PSEUDOMYXOMA PERITONEI OF APPENDICEAL ORIGIN, European journal of cancer, 32A(10), 1996, pp. 1727-1733
Authors:
JACQUET P
STUART OA
CHANG D
SUGARBAKER PH
Citation: P. Jacquet et al., EFFECTS OF INTRAABDOMINAL PRESSURE ON PHARMACOKINETICS AND TISSUE DISTRIBUTION OF DOXORUBICIN AFTER INTRAPERITONEAL ADMINISTRATION, Anti-cancer drugs, 7(5), 1996, pp. 596-603
Citation: P. Jacquet et Ph. Sugarbaker, WOUND RECURRENCE AFTER LAPAROSCOPIC COLECTOMY FOR CANCER - NEW RATIONALE FOR INTRAOPERATIVE INTRAPERITONEAL CHEMOTHERAPY, Surgical endoscopy, 10(3), 1996, pp. 295-296
Citation: P. Jacquet et Ph. Sugarbaker, CURRENT METHODOLOGIES FOR CLINICAL-ASSESSMENT OF PATIENTS WITH PERITONEAL CARCINOMATOSIS, Journal of experimental & clinical cancer research, 15(1), 1996, pp. 49-58